3291.0 Comorbidity & addiction: Program design and outcome

Monday, November 9, 2009: 2:30 PM
Oral
Moderator:
Bettina Scott, PhD

2:30 PM
Heroin use outcomes for integrated HIV/buprenorphine treatment programs
James E. Egan, MPH, Michael Botsko, MSW, Linda Weiss, PhD, Julie Netherland, MSW, Ruth Finkelstein, ScD and David Fiellin, MD
  
2:48 PM
Impact of co-location of substance abuse and chronic disease treatment
Carlota John-Hull, MD, Steven Kritz, MD, Melissa Chu, MS, Charles Madray, RPA-C, MBA, Roberto Zavala, MD and Lawrence S. Brown, MD, MPH, FASAM
  
3:06 PM
Mental Health Indicator Interaction and Substance Abuse Treatment Outcomes in Nevada
Lawrence Greenfield and Michael Wolf-Branigin, PhD
        
3:24 PM
Disparities in Co-occurring Mental Health Problems among Substance Abusing Black Youth with Single- and Multi-race Identities
Mesfin S. Mulatu, PhD, MPH, Dionne C. Godette, PhD, Kimberly Jeffries Leonard, PhD and Suzanne M. Randolph, PhD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: Social Work

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: Alcohol, Tobacco, and Other Drugs
<< Previous Session | Next Session >>